Participant guide
How studies are reviewed and monitored
A cancer clinical trial cannot enroll you, or the person you are reading for, until an independent committee has reviewed it. The review does not stop there. It continues for as long as the study runs.
Updated
Independent review
The committee is called an Institutional Review Board, or IRB. It is independent of the researchers. Before a cancer trial starts, the IRB reviews both the study plan and the consent document, and its review continues while the trial is under way. The rights and welfare of participants are what it exists to protect.
Who runs cancer studies
As of November 16, 2026, 3,223 cancer studies are recruiting participants in the United States, according to ClinicalTrials.gov. By sponsor: university, hospital or other (2,153), industry (913), government (157). The sponsor is the organization responsible for a study.
Federal rules
Cancer clinical trials in the United States run under federal rules. Those rules spell out what you, or the person you are caring for, have to be told when taking part and which protections apply. The U.S. Food and Drug Administration adds its own oversight whenever a study tests a medication or device.
Monitoring during the study
At scheduled visits, the study team checks on your health and records any problems you report. A study can be changed, paused, or stopped if a serious concern appears.
All of this oversight reduces risk without removing it. No cancer study is free of risk. The risks that are known are described in the consent document.
Talk with a study coordinator
You can reach Oncology Research Hub at (888) 343-1186 or by sending a short form. A coordinator will explain which cancer studies may fit and what the next step looks like. Asking questions, for yourself or for a family member, commits you to nothing.
Sources and further reading
- Institutional Review Boards (IRBs) and Protection of Human Subjects in Clinical Trials — U.S. Food and Drug Administration
- Regulations to Protect Research Participants — HHS Office for Human Research Protections
- 45 CFR 46 — Protection of Human Subjects — U.S. Department of Health and Human Services